Live Oak Acquisition in an 8-K filing announced that shareholders approved to proposed merger with Danimer Scientific.
Terms of the $525 million deal for the bioplastic company also calls for Danimer to trade on the NYSE. The transaction implies an equity valuation for Danimer of approximately $890 million at closing. Read more.
Related Posts
INFINT Acquisition Wins Another Extension on Seamless Deal
The deal was announced in August 2022 at a $400 million enterprise value.
Vickers Vantage I Registers $100M IPO
The Singapore-based SPAC said it has not focused on any specific sector for a potential business combination.
Pontem Upsizes IPO by 33% to $500M
Pontem said it plans to target high growth, hybrid “industrial and technology” players in a prime position to reshape the industrial landscape.
Horizon II Circling Sportradar: Report
Swiss gambling data company Sportradar AG is in talks to go public through Todd Boehly’s Horizon Acquisition II, Bloomberg reports.